Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume $11.00 +0.26 (+2.42%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Astellas Pharma Short Interest DataCurrent Short Interest338,900 sharesPrevious Short Interest227,800 sharesChange Vs. Previous Month+48.77%Dollar Volume Sold Short$3.53 millionShort Interest Ratio1.0 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares1,809,660,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume399,979 sharesAverage Trading Volume294,289 sharesToday's Volume Vs. Average136% Short Selling Astellas Pharma ? Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPMY Short Interest Over TimeALPMY Days to Cover Over TimeALPMY Percentage of Float Shorted Over Time Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. Astellas Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2024338,900 shares $3.53 million +48.8%N/A1 $10.42 6/30/2024227,800 shares $2.25 million -10.5%N/A0.4 $9.86 6/15/2024254,500 shares $2.42 million +83.5%N/A0.3 $9.51 5/31/2024138,700 shares $1.36 million +87.2%N/A0.2 $9.81 5/15/202474,100 shares $726,180.00 -11.7%N/A0.1 $9.80 4/30/202483,900 shares $801,245.00 +20.2%N/A0.1 $9.55 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27 3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75 3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83 2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93 2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05 1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08 12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90 12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36 11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16 11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65 10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69 10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04 9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85 9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91 8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14 8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13 7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63 7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40 6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87 6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12 5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77 5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03 4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02 4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81 3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20 3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77 2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00 2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37 1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68 1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62 12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16 12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57 11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46 11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86 10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33 9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33 9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77 8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30 7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57 7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82 6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56 6/15/202239,200 shares $587,216.00 +1,087.9%N/A0.2 $14.98 5/31/20223,300 shares $52,503.00 -85.3%N/A0 $15.91 5/15/202222,400 shares $339,360.00 -62.5%N/A0.1 $15.15 4/30/202259,700 shares $905,649.00 +69.1%N/A0.3 $15.17 4/15/202235,300 shares $580,685.00 +451.6%N/A0.2 $16.45 3/31/20226,400 shares $99,712.00 +220.0%N/A0 $15.58 3/15/20222,000 shares $31,320.00 -75.3%N/A0 $15.66 2/28/20228,100 shares $135,108.00 -77.7%N/A0 $16.68 2/15/202236,300 shares $627,046.20 -17.7%N/A0.2 $17.27 1/31/202244,100 shares $712,215.00 -4.8%N/A0.2 $16.15 1/15/202246,300 shares $764,413.00 +282.6%N/A0.3 $16.51 12/31/202112,100 shares $196,867.00 -55.4%N/A0.1 $16.27 12/15/202127,100 shares $431,161.00 -13.1%N/A0.1 $15.91 11/30/202131,200 shares $485,316.00 -50.9%N/A0.2 $15.56 11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37 10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88 10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55 9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52 9/15/202137,000 shares $629,000.00 +380.5%N/A0.4 $17.00 8/31/20217,700 shares $129,206.00 +3,750.0%N/A0.1 $16.78 8/13/2021200 shares $3,246.00 -97.2%N/A0 $16.23 7/30/20217,200 shares $114,624.00 -36.8%N/A0.1 $15.92 7/15/202111,400 shares $198,474.00 -81.7%N/A0.1 $17.41 6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38 6/15/202151,600 shares $904,548.00 -28.3%N/A0.3 $17.53 5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22 5/14/202114,100 shares $215,166.00 +1,914.3%N/A0.1 $15.26 4/30/2021700 shares $10,461.50 -82.1%N/A0 $14.95 4/15/20213,900 shares $58,812.00 -76.4%N/A0 $15.08 3/31/202116,500 shares $258,060.00 +66.7%N/A0.2 $15.64 3/15/20219,900 shares $164,835.00 -73.9%N/A0.1 $16.65 2/26/202137,900 shares $626,108.00 -41.4%N/A0.5 $16.52 2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99 1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38 1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91 12/31/202017,600 shares $271,040.00 -56.4%N/A0.1 $15.40 12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59 11/30/202061,200 shares $954,108.00 +367.2%N/A0.5 $15.59 11/15/202013,100 shares $203,312.00 +718.8%N/A0.1 $15.52 10/30/20201,600 shares $22,256.00 -88.8%N/A0 $13.91 10/15/202014,300 shares $202,488.00 +44.4%N/A0.1 $14.16 9/30/20209,900 shares $147,609.00 +125.0%N/A0.1 $14.91“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 9/15/20204,400 shares $67,056.00 -91.3%N/A0 $15.24 8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67 8/14/20206,500 shares $106,340.00 -59.4%N/A0.1 $16.36 7/31/202016,000 shares $251,168.00 +742.1%N/A0.1 $15.70 7/15/20201,900 shares $31,027.00 -96.6%N/A0 $16.33 6/30/202056,000 shares $932,960.00 +266.0%N/A0.6 $16.66 6/15/202015,300 shares $251,945.10 +393.6%N/A0.1 $16.47 5/29/20203,100 shares $55,304.00 -35.4%N/A0 $17.84 5/15/20204,800 shares $76,800.00 -66.0%N/A0.1 $16.00 4/30/202014,100 shares $230,535.00 +65.9%N/A0.1 $16.35 4/15/20208,500 shares $138,805.00 +7.6%N/A0.1 $16.33 3/31/20207,900 shares $129,165.00 -92.7%N/A0 $16.35 3/13/2020107,900 shares $1.67 million +233.0%N/A0.7 $15.52 2/28/202032,400 shares $427,032.00 -20.6%N/A0.4 $13.18 2/14/202040,800 shares $641,376.00 +164.9%N/A0.5 $15.72 1/31/202015,400 shares $249,172.00 -32.5%N/A0.3 $16.18 1/15/202022,800 shares $418,608.00 -30.3%N/A0.3 $18.36 12/31/201932,700 shares $569,307.00 +1,621.1%N/A0.5 $17.41 ALPMY Short Interest - Frequently Asked Questions What is Astellas Pharma's current short interest? Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 338,900 shares of ALPMY short. Learn More on Astellas Pharma's current short interest. What is a good short interest ratio for Astellas Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALPMY shares currently have a short interest ratio of 1.0. Learn More on Astellas Pharma's short interest ratio. Is Astellas Pharma's short interest increasing or decreasing? Astellas Pharma saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 338,900 shares, an increase of 48.8% from the previous total of 227,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Astellas Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Astellas Pharma: Takeda Pharmaceutical Company Limited (0.20%), Alnylam Pharmaceuticals, Inc. (3.55%), Merck KGaA (0.33%), Teva Pharmaceutical Industries Limited (1.56%), Genmab A/S (0.34%), Royalty Pharma plc (4.29%), BioMarin Pharmaceutical Inc. (3.93%), BeiGene, Ltd. (1.67%), United Therapeutics Co. (9.57%), Sarepta Therapeutics, Inc. (7.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Astellas Pharma stock? Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading up $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astellas Pharma? A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further. How often is Astellas Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TAK Short Interest ALNY Short Interest BAYRY Short Interest MKGAF Short Interest TEVA Short Interest GMAB Short Interest RPRX Short Interest BMRN Short Interest BGNE Short Interest UTHR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ALPMY) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astellas Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.